The efficacy and tolerability of liraglutide (daily s/c GLP1a) have been reported elsewhere [7,8,9] and have been shown to improve weight loss outcomes in that where satisfactory weight loss following surgery has not been achieved [10]
In addition, pure-type DMs have a less aggressive clinical course than mixed DMs, with a 5-year melanoma-specific mortality rate of 11 vs
The good news is that this question has been studied carefully, and the answers are more nuancedand reassuringthan social media headlines suggest
B: They dont own all their data
The treatment will also help with recovery and tissue fixes
Some evidence also suggests that GLP-1 RAs mitigate kidney function loss, especially in patients with evidence of kidney disease [12, 16], and this subject is being formally tested in the FLOW trial [17]